BIIB
Biogen Inc.
215.50$
-1.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.3% | 34.5% | 39.5% | 37.1% | 46.0% | 49.2% | 31.5% | 33.1% | 13.6% | 15.7% | 29.7% | 22.5% | |
| 6.6% | 5.6% | 6.0% | 8.8% | 4.8% | 3.2% | 3.4% | 4.4% | 5.1% | 5.0% | 7.0% | 7.9% | |
| 1.6% | 1.5% | 1.4% | 1.0% | 1.2% | 1.3% | 1.5% | 2.2% | 2.5% | 2.7% | 3.0% | 3.0% | |
| -2.1% | 0.9% | 0.6% | 4.6% | 2.2% | 1.8% | 5.0% | 6.8% | -14.5% | – | – | – | |
| -5.0% | -5.3% | 0.6% | 1.9% | 3.0% | 1.4% | -1.4% | -1.3% | -8.8% | -6.6% | -1.6% | -10.8% | |
| 3.0% | 6.0% | 5.4% | 7.1% | 5.7% | 3.6% | 4.1% | 2.7% | 2.4% | 3.2% | 3.7% | 1.6% | |
| -15.9% | -42.3% | -21.7% | -24.1% | -15.2% | 3.3% | -4.5% | -5.1% | 15.6% | -41.6% | -8.3% | -14.0% | |
| 565.1% | 55.1% | 0.0% | 2.5% | 0.3% | – | 0.0% | 0.0% | – | – | – | – | |
| -9.1% | -46.5% | -8.7% | -11.1% | -32.4% | -40.8% | -49.7% | -16.4% | -7.4% | 0.0% | 0.0% | – | |
| 0.0% | 55.1% | 0.0% | -4.6% | 0.0% | 10.2% | 10.9% | -1.5% | -9.9% | 1.9% | -6.7% | -0.2% | |
| -7.8% | 9.2% | -8.6% | -19.4% | -33.2% | -40.8% | -39.2% | -19.0% | -17.3% | 1.4% | -7.1% | -3.1% | |
| 6.2% | 1.0% | 8.9% | -6.1% | -2.6% | 11.7% | -11.8% | 8.5% | 11.4% | -24.1% | 13.7% | 6.5% | |
| 27.1% | 28.6% | 33.7% | 30.0% | 39.4% | 45.7% | 27.4% | 30.5% | 11.2% | 12.6% | 26.0% | 20.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.